Achieve Life Sciences ACHV Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.46M-18.9% | $14.73M+20.8% | $14.69M+17.9% | $12.56M+49.0% | $12.89M+116% | ||
| $274K+48.1% | $251K+27.4% | $192K-47.5% | $191K-76.2% | $185K-77.2% | ||
| $295K+340% | $69K+141% | $251K+646% | -$155K-417% | $67K+113% | ||
| —— | 0%— | —— | —— | —— | ||
| -$10.17M+20.7% | -$14.66M-18.6% | -$14.44M-15.4% | -$12.72M-50.3% | -$12.83M-97.5% | ||
| -$0.19+48.6% | -$0.26+27.8% | -$0.28+22.2% | -$0.37-48.0% | -$0.37-42.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Achieve Life Sciences profitable?
- Achieve Life Sciences is not currently profitable: it reported a net loss of $52.0M over the trailing twelve months.
- What is Achieve Life Sciences's earnings per share?
- Achieve Life Sciences's diluted EPS over the trailing twelve months is $-1.10.
- Where does Achieve Life Sciences's income statement data come from?
- Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.